Carmine Stengone

Carmine Stengone

Directeur Général chez CONTINEUM THERAPEUTICS, INC.

Fortune : 235 607 $ au 31/05/2026

50 ans
Health Technology
Consumer Services
Commercial Services

Profil

Mr. Carmine N.
Stengone
is an Independent Director at Kiora Pharmaceuticals, Inc. and a President, Chief Executive Officer & Director at Contineum Therapeutics, Inc. He is on the Board of Directors at Kiora Pharmaceuticals, Inc. and Contineum Therapeutics, Inc. Mr. Stengone was previously employed as a Senior Vice President-Business Development by COI Pharmaceuticals, Inc., a President, Chief Executive Officer & Director by Avelas Biosciences, Inc., a President, Chief Executive Officer & Director by Afraxis, Inc., a Senior Director-Business Development by Phenomix Corp., a Senior Manager-Strategic Marketing by Anadys Pharmaceuticals, Inc., and a Principal by Johnson & Johnson Pharmaceutical Research & Development LLC.
He received his undergraduate degree from Wake Forest University, a graduate degree from Duke University and an MBA from Johnson Graduate School of Management.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
30/06/2026 17 217 ( 0,05 % ) 232 257 $ 31/05/2026
10/06/2026 1 250 ( 0,03 % ) 3 350 $ 31/05/2026

Postes actifs de Carmine Stengone

SociétésPosteDébut
CONTINEUM THERAPEUTICS, INC. Directeur Général 01/10/2018
KIORA PHARMACEUTICALS, INC. Directeur/Membre du Conseil 01/08/2023

Anciens postes connus de Carmine Stengone

SociétésPosteFin
Directeur Général 01/01/2018
Corporate Officer/Principal 01/10/2018
Corporate Officer/Principal 28/10/2010
Sales & Marketing 01/01/2006
Corporate Officer/Principal 01/01/2004
Voir l'expérience en détail de Carmine Stengone

Formation de Carmine Stengone

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

88

Relations au 1er degré

11

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées11

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Commercial Services

Consumer Services

Health Services

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. Carmine Stengone
🔇